Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Odour Free Evaporation on Users Lab Bench
Wednesday, June 04, 2014
“Odour Reduction” function for Genevac’s EZ-2 evaporator.

Higher Performance from Vacuum Jacketed Reactor System
Wednesday, June 04, 2014
Asynt’s ReactoMate Reactor System provides excellent reaction visibility and reduces condensation.

CCBT at inStem Licenses Cresset’s Computational Tools
Tuesday, June 03, 2014
Three year license to use Forge and Spark software tools for lead optimization and identification.

Embase Enhances Adverse Event Monitoring
Friday, May 30, 2014
With Embase and PharmaPendium, researchers can monitor pre-clinical, clinical and post-market information from a single search - improving pharmacovigilance and risk monitoring.

Extraordinary Tools for Exceptional Results
Wednesday, May 28, 2014
New Rainin Pipet-Lite™ XLS+™ manual pipettes from Anachem.

New Undergrad Hotplate Stirrers from Stuart
Saturday, May 24, 2014
New models deliver upmost levels of control and accuracy.

Malvern Publishes New Whitepaper that Explores AQbD
Friday, May 16, 2014
The whitepaper is freely available for download from http://www.malvern.com/beyond_sops.

Shimadzu Introduces C2P Automated Purification/Powderization System
Thursday, May 15, 2014
Crude2Pure for improved purity, efficiency and productivity.

Field Based Chemistry North America and Europe
Tuesday, May 13, 2014
North America and European meeting takes place on June 11th, 2014 and June 19th - 20th, 2014 respectively.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 1277
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv